302 related articles for article (PubMed ID: 26256788)
1. The yin and yang of hepatitis C: synthesis and decay of hepatitis C virus RNA.
Li Y; Yamane D; Masaki T; Lemon SM
Nat Rev Microbiol; 2015 Sep; 13(9):544-58. PubMed ID: 26256788
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-mediated interactions between host and hepatitis C virus.
Li H; Jiang JD; Peng ZG
World J Gastroenterol; 2016 Jan; 22(4):1487-96. PubMed ID: 26819516
[TBL] [Abstract][Full Text] [Related]
3. Oligonucleotide-based therapeutic options against hepatitis C virus infection.
Trepanier JB; Tanner JE; Alfieri C
Antivir Ther; 2006; 11(3):273-87. PubMed ID: 16759043
[TBL] [Abstract][Full Text] [Related]
4. Potential applications of siRNA in hepatitis C virus therapy.
Smolic R; Volarevic M; Wu CH; Wu GY
Curr Opin Investig Drugs; 2006 Feb; 7(2):142-6. PubMed ID: 16499284
[TBL] [Abstract][Full Text] [Related]
5. Differences in viral dynamics between genotypes 1 and 2 of hepatitis C virus.
Neumann AU; Lam NP; Dahari H; Davidian M; Wiley TE; Mika BP; Perelson AS; Layden TJ
J Infect Dis; 2000 Jul; 182(1):28-35. PubMed ID: 10882578
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA profile before and after antiviral therapy in liver transplant recipients for hepatitis C virus cirrhosis.
Gelley F; Zadori G; Nemes B; Fassan M; Lendvai G; Sarvary E; Doros A; Gerlei Z; Nagy P; Schaff Z; Kiss A
J Gastroenterol Hepatol; 2014 Jan; 29(1):121-7. PubMed ID: 24033414
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.
Eyre NS; Phillips RJ; Bowden S; Yip E; Dewar B; Locarnini SA; Beard MR
J Hepatol; 2009 Sep; 51(3):446-57. PubMed ID: 19596477
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus persistence after sustained virological response to antiviral therapy in patients with or without past exposure to hepatitis B virus.
Pham TN; Coffin CS; Churchill ND; Urbanski SJ; Lee SS; Michalak TI
J Viral Hepat; 2012 Feb; 19(2):103-11. PubMed ID: 21699630
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C.
Pham TN; MacParland SA; Mulrooney PM; Cooksley H; Naoumov NV; Michalak TI
J Virol; 2004 Jun; 78(11):5867-74. PubMed ID: 15140984
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus entry.
Zeisel MB; Felmlee DJ; Baumert TF
Curr Top Microbiol Immunol; 2013; 369():87-112. PubMed ID: 23463198
[TBL] [Abstract][Full Text] [Related]
11. Interaction of host cell microRNAs with the HCV RNA genome during infection of liver cells.
Sedano CD; Sarnow P
Semin Liver Dis; 2015 Feb; 35(1):75-80. PubMed ID: 25632937
[TBL] [Abstract][Full Text] [Related]
12. Viral kinetics and early prediction of nonresponse to peg-IFN-alpha-2b plus ribavirin in HCV genotypes 1/4 according to HIV serostatus.
Moreno A; Bárcena R; García-Garzón S; Moreno L; Quereda C; Muriel A; Zamora J; Mateos ML; Pérez-Elías MJ; Antela A; Diz S; Moreno A; Moreno S
J Viral Hepat; 2006 Jul; 13(7):466-73. PubMed ID: 16792540
[TBL] [Abstract][Full Text] [Related]
13. New kinetic models for the hepatitis C virus.
Perelson AS; Herrmann E; Micol F; Zeuzem S
Hepatology; 2005 Oct; 42(4):749-54. PubMed ID: 16175615
[TBL] [Abstract][Full Text] [Related]
14. Response to combined interferon and ribavirin is better in patients infected with hepatitis C virus genotype 6 than genotype 1 in Hong Kong.
Yuen MF; Lai CL
Intervirology; 2006; 49(1-2):96-8. PubMed ID: 16166796
[TBL] [Abstract][Full Text] [Related]
15. A Hepatitis C virus-host interaction involved in viral replication: toward the identification of antiviral targets.
Suzuki T
Jpn J Infect Dis; 2010 Sep; 63(5):307-11. PubMed ID: 20858994
[TBL] [Abstract][Full Text] [Related]
16. [Determination of the in vitro antiviral activity of an engineered M1GS ribozyme that targets to the core gene of hepatitis C virus].
Zhang W; Li X; Luo G; Huang Z; Liu Y
Wei Sheng Wu Xue Bao; 2013 Aug; 53(8):875-81. PubMed ID: 24341280
[TBL] [Abstract][Full Text] [Related]
17. Lipids: a key for hepatitis C virus entry and a potential target for antiviral strategies.
Blaising J; Pécheur EI
Biochimie; 2013 Jan; 95(1):96-102. PubMed ID: 22884392
[TBL] [Abstract][Full Text] [Related]
18. Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo.
Zeuzem S; Schmidt JM; Lee JH; Rüster B; Roth WK
Hepatology; 1996 Feb; 23(2):366-71. PubMed ID: 8591865
[TBL] [Abstract][Full Text] [Related]
19. Twenty-four hour kinetics of hepatitis C virus and antiviral effect of alpha-interferon.
Boulestin A; Kamar N; Sandres-Sauné K; Legrand-Abravanel F; Alric L; Vinel JP; Rostaing L; Izopet J
J Med Virol; 2006 Mar; 78(3):365-71. PubMed ID: 16419107
[TBL] [Abstract][Full Text] [Related]
20. Low hepatitis C viral load predicts better long-term outcomes in patients undergoing resection of hepatocellular carcinoma irrespective of serologic eradication of hepatitis C virus.
Shindoh J; Hasegawa K; Matsuyama Y; Inoue Y; Ishizawa T; Aoki T; Sakamoto Y; Sugawara Y; Makuuchi M; Kokudo N
J Clin Oncol; 2013 Feb; 31(6):766-73. PubMed ID: 23129744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
